Science Translational Medicine reports that a new drug originally developed for type 2 diabetes is being prepared for human clinical trials in hope of finding the world's first treatment to slow Parkinson's disease.
The drug was developed by Kalamazoo-based Metabolic Solutions Development Company and supported by research from Van Andel Research Institute's Center for Neurodegenerative Science.
Re